Cargando…
Durvalumab/everolimus: Lung toxicity and pulmonary sarcoidosis: 2 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787616/ http://dx.doi.org/10.1007/s40278-021-88129-1 |
Ejemplares similares
-
Coexistence of pulmonary tuberculosis with pulmonary sarcoidosis and skin sarcoidosis: a case report
por: Yusuf, Khalifa Abdulrahman, et al.
Publicado: (2023) -
Durvalumab: Immune-related pneumonitis: case report
Publicado: (2021) -
Durvalumab/elasomeran: Immune thrombocytopenia: case report
Publicado: (2022) -
Durvalumab induced sarcoid‐like pulmonary lymphadenopathy
por: Sanderson, Emma, et al.
Publicado: (2020) -
Long‐term response with durvalumab after chemoradiotherapy for pulmonary pleomorphic carcinoma: A case report
por: Yorozuya, Takafumi, et al.
Publicado: (2020)